Clinical Trial Update: A Study to Learn How Patients With Triple Class Refractory Multiple Myeloma (TCR-MM) Are Treated in Italian Centers for Blood Related Diseases

View source ↗

Summary

Pfizer-sponsored observational study in Italian hematology centers aims to understand how patients with triple class refractory multiple myeloma are treated. Th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Snippet

Sponsor: Pfizer | Conditions: Relapse Multiple Myeloma, Refractory Multiple Myeloma | Status: ACTIVE_NOT_RECRUITING